Cancer Lett. 2011 Dec 17. [Epub ahead of print]
Cardamonin inhibits osteoclastogenesis induced by tumor cells throughinterruption of the signaling pathway activated by receptor activator of NF-κBligand.
Source
Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
WITHDRAWN:
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause.
The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.
0 件のコメント:
コメントを投稿